日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types

出版商更正:针对LGR5的新型免疫疗法可靶向多种癌症类型

Chen, Hung-Chang; Mueller, Nico; Stott, Katherine; Kapeni, Chrysa; Rivers, Eilidh; Sauer, Carolin M; Beke, Flavio; Walsh, Stephen J; Ashman, Nicola; O'Brien, Louise; Rafati Fard, Amir; Ghodsinia, Arman; Li, Changtai; Joud, Fadwa; Giger, Olivier; Zlobec, Inti; Olan, Ioana; Aitken, Sarah J; Hoare, Matthew; Mair, Richard; Serrao, Eva; Brenton, James D; Garcia-Gimenez, Alicia; Richardson, Simon E; Huntly, Brian; Spring, David R; Skjoedt, Mikkel-Ole; Skjødt, Karsten; de la Roche, Marc; de la Roche, Maike

FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy.

FOXC2 促进血管生成拟态和抗血管生成疗法的耐药性

Cannell Ian G, Sawicka Kirsty, Pearsall Isabella, Wild Sophia A, Deighton Lauren, Pearsall Sarah M, Lerda Giulia, Joud Fadwa, Khan Showkhin, Bruna Alejandra, Simpson Kathryn L, Mulvey Claire M, Nugent Fiona, Qosaj Fatime, Bressan Dario, Dive Caroline, Caldas Carlos, Hannon Gregory J

Upconversion nanoparticles as intracellular pH messengers

上转换纳米粒子作为细胞内pH信使

Tsai, Evaline S; Joud, Fadwa; Wiesholler, Lisa M; Hirsch, Thomas; Hall, Elizabeth A H